Perlen Packaging, the packaging division of Switzerland-based CPH Chemie + Papier Holding AG, has announced the extension of its polyvinylidene chloride (PVdC) coating line in Perlen, Switzerland. The company is investing more than 20 million Swiss francs ($20.84 million) in the extension of its production capacities in Europe and Asia for pharmaceutical films.
“The pharma markets in Europe are continually growing and the demand for barrier films is increasing,” said Johannes Giessler, director of sales and marketing of Perlen Packaging in a news release.
“Thanks to the continuous investments in our technology and our GMP standard production facilities in Germany and Switzerland, we can ensure the continued availability of our high-quality products for the European pharmaceutical market,” he added.
Perlen Packaging is also setting up a production facility for the Asian market. The groundbreaking ceremony for the new site took place in Wujiang, China in spring 2015 and the company states that the plant will be ready to deliver its first products during 2016.
“The Asian pharmaceutical markets are showing double-digit growth rates. As the first foreign company to set up a production facility in China, Perlen Packaging's aim is to cater to the expected growth in the region and to better serve the markets from a local site,” said Wolfgang Grimm CEO of Perlen Packaging in a statement.
Perlen Packaging currently has three manufacturing plants in Switzerland, Germany and the U.S. The company saw sales of 117.8 million Swiss francs ($120.6 million) in 2014 and employs 307 people.
